New drug algorithm aims to quickly lower blood pressure in brain bleed patients

NCT ID NCT07044232

Recruiting now Disease control Sponsor: Aarhus University Hospital Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether using a nicardipine infusion (a fast-acting blood pressure drug) can help more stroke patients with brain bleeding reach a safe blood pressure within one hour of arriving at the hospital. About 88 adults with acute intracerebral hemorrhage and high blood pressure will be enrolled. The study compares a new treatment algorithm using nicardipine to the current standard care with nitroglycerin patches.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Nicardipine (given as an infusion) compared to glyceryl trinitrate patches
What this could lead to: If successful, this could show that a fast-acting blood pressure drug helps more stroke patients reach safe blood pressure levels quickly, potentially improving recovery.
What could go wrong: This is a small, early-phase implementation study, not a large definitive trial. The results may not apply to all patients, and the drug may not improve long-term outcomes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for INTRACEREBRAL HAEMORRHAGE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

intracerebral hemorrhage

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

INTRACEREBRAL HAEMORRHAGE

Contacts and locations

Locations

Aarhus University Hospital
RECRUITING

Aarhus, 8200, Denmark

More trials for these conditions

Other studies related to the condition(s) this trial covers.